MedTrace Logo

Intensive Blood Pressure and LDL Lowering in Diabetic Patients With Coronary Artery Disease

NCT01422421 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 798

Last updated 2024-06-14

No results posted yet for this study

Summary

The purpose of this study is to determine whether intensive blood pressure and low density lipoprotein (LDL) cholesterol lowering could improve survival and cardiovascular outcome in Japanese diabetic patients with coronary artery disease and history of acute coronary syndrome.

Conditions

Interventions

OTHER

intensive control

use any medication to achieve systolic blood pressure less than 120mmHg and LDL cholesterol within 70-85mg/dl

OTHER

standard control

use any medication to achieve systolic blood pressure less than 130mmHg and LDL cholesterol less than 100mg/dl

Sponsors & Collaborators

  • University of the Ryukyus

    collaborator OTHER

  • Takeshi Morimoto

    lead OTHER

Principal Investigators

  • Shinichiro Ueda, MD, PhD · Professor of Clinical Pharmacology and Therapeutics, University of the Ryukyus

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2022-03-31
Completion
2023-12-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01422421 on ClinicalTrials.gov